Skip to main content
TipRanks
Go Ultimate75% OFF

Bioxcel Therapeutics (BX20) Q2 2024 Earnings Report

10 Followers

DE:BX20 Q2 2024 EPS Results

Actual EPS
-EUR 3.06
Consensus EPS
-EUR 10.39
Beat/Miss
Beat by +EUR 7.33
One Year Ago EPS
-EUR 26.69

DE:BX20 Q2 2024 Revenue Results

Actual Revenue
EUR 1.01M
Expected Revenue
EUR 694.62K
Beat/Miss
Beat by +EUR 311.76K
YoY Revenue Growth
+141.58%

Earnings Announcement Details

Quarter
Q2 2024
Date
08/06/2024
Time
Before Open
Conference Call
Tuesday, August 6, 2024
DE:BX20 Upcoming Earnings

Bioxcel Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

DE:BX20 Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:BX20 Earnings History

DE:BX20 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 11, 20272026 (Q4)―--0.53――
Nov 18, 20262026 (Q3)-0.92--1.99―
Aug 11, 20262026 (Q2)-0.40-0.44-2.2380.16% (+1.79)
May 15, 20262026 (Q1)-0.48-0.49-1.3764.00% (+0.88)
Mar 27, 20262025 (Q4)-0.58-0.53-3.2583.75% (+2.73)
Nov 12, 20252025 (Q3)-1.22-1.99-4.6757.42% (+2.68)
Aug 12, 20252025 (Q2)-1.69-2.23-3.0627.08% (+0.83)
May 12, 20252025 (Q1)-2.48-1.37-12.6989.22% (+11.32)
Mar 27, 20252024 (Q4)-5.51-3.25-11.0870.64% (+7.83)
Nov 14, 20242024 (Q3)-7.37-4.67-25.0981.40% (+20.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed